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Increased Risk of Mortality From Overweight and
Obesity in Middle-aged Individuals From Six
Communities in Taiwan
Lee-Ching Hwang,1,2 Su-Chiu Chen,3* Chien-Jen Chen4,5
Background/Purpose: Although obesity is becoming a major public health problem, data are limited on
the relationship between body mass index (BMI) and survival in Taiwanese populations. Therefore, the
aim of this study was to evaluate the long-term effects of obesity on the risk of death from any cause and
from specific diseases in middle-aged Taiwanese adults.
Methods: We investigated the association between BMI and mortality in a prospective cohort study. In all,
6603 men and women (age range, 20–65 years) were included.
Results: The mean BMI at baseline was 22.7 kg/m2. During an average 24-year follow-up, 1896 of the
6603 individuals died (28.7%). The relationship between death from any cause and BMI followed a 
J-shaped pattern. Hazard ratio (HR) estimates for all-cause mortality increased among participants who
were obese [HR: 1.28, 95% confidence interval (CI): 1.12–1.47 for BMI 25–26.9 kg/m2; HR: 1.46, 95% CI:
1.27–1.68 for BMI ≥ 27 kg/m2]. This positive association was mainly observed in deaths from diabetes,
cardiovascular diseases, or cancer. The HRs for diabetes mortality were significantly higher at BMI ≥
23.0 kg/m2 (HR: 1.93, 95% CI: 1.33–2.81 for BMI 23–24.9 kg/m2; HR: 2.59, 95% CI: 0.71–3.90 for BMI
25–26.9 kg/m2; and HR: 3.03, 95% CI: 2.01–4.58 for BMI ≥ 27 kg/m2).
Conclusion: Increasing BMI (≥ 23 kg/m2) was positively associated with deaths from diabetes and cardio-
vascular diseases. We found that BMI ≥ 25 kg/m2 was a significant predictor for all-cause mortality and
≥ 27 kg/m2 was a significant predictor for cancer mortality. The relationship between BMI and mortality
was J-shaped in Taiwanese adults.
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Currently, one-third of Taiwanese adults are esti-
mated to be overweight or obese.1 Obesity is asso-
ciated with a variety of diseases,2–5 including type 2
diabetes, cardiovascular disease (CVD), and cancer,
which contribute to increased mortality; thus, obe-
sity is becoming a major public health problem.
According to the Global Burden of Disease
Study, excess adiposity is ranked fifth highest for
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disease burden and fourth highest for cause of
death worldwide.6 The mean loss of life attributed
to obesity is at least 2 years. The effects of obesity
are more marked in young men, therefore, this fig-
ure could be as high as 10–20 years.7,8 Large cohort
studies have confirmed that body mass index (BMI)
and mortality exhibit a classical J- or U-shaped
curve in the United States,9 South Korea,10 and
China,11 with the optimum BMI being 23–25 kg/
m2. Previous research on the Cancer Prevention
Study (CPS) II has shown that being overweight
or obese is positively associated with an increased
risk of all-cause mortality.12 The mortality rate was
the lowest among men with a BMI of 23.5–
24.9kg/m2 and among women with a BMI of 22.0–
23.4 kg/m2. Obesity-related excess mortality can
occur due to CVD, cancer, and all other causes.11
Data are limited on the relationship between
obesity and survival in Taiwanese populations.
The purpose of this study was to assess the asso-
ciation of BMI with the risk of death from any
cause and from specific diseases in middle-aged
Taiwanese adults.
Materials and Methods
Subjects
Between October 1982 and September 1983, the
baseline cohort for the Six-Community Hyper-
tension Intervention Project (SCHIP) study was
established to collect information on the health
status of patients with hypertension and CVD
across six communities in Taiwan.13,14 In all,
7763 subjects recruited through stratified system-
atic clustering sampling participated in a nation-
wide population-based survey. The following six
communities were included in the survey: Nan-
Gang District in Taipei City, Nantz District in Kao-
hsiung City, Dounan Township in Yunlin County,
Dayuan Township in Taoyuan County, Jhunan
Township in Miaoli County, and Dashu Township
in Kao-hsiung County. All the subjects provided
written informed consent for participation.
Subjects with a history of stroke or cancer at
baseline or who were older than 65 years were
excluded. We also excluded subjects who died
during the first 3 years of follow-up to exclude
deaths from unintentional weight loss or wasting
diseases. In all, 6603 subjects (age, 20–65 years)
were included in this study.
Data collection
All participants were interviewed at home. Socio-
demographic data, including sex, age, smoking
status, alcohol consumption, exercise habits, and
physician-diagnosed diseases, were documented
using questionnaires administered by trained
nurses. During the first visit in 1982, sitting
blood pressure and anthropometric indexes were
measured.2 Smoking status during the previous 
3 months was categorized as current, past, or
never. Alcohol consumption was categorized 
as frequent (more than once weekly), less fre-
quent, or never. Exercise habits defined as regu-
lar exercise of > 30 minutes during the previous 
3 months were categorized as frequent (more
than twice weekly), less frequent, or never. Almost
half of the participants were randomly sampled
for blood biochemistry analysis in the following
year.
According to the BMI cutoff values suggested
for Asians,15 subjects were classified into under-
weight (BMI: < 18.5 kg/m2), normal weight (BMI:
18.5–22.9 kg/m2), overweight (BMI: 23–24.9 kg/
m2), and obese (BMI: ≥ 25 kg/m2). To fit the obe-
sity category (BMI: ≥ 27 kg/m2) according to the
Department of Health, Taiwan, we divided the
obesity groups into two: BMI: 25–26.9 kg/m2 and
≥ 27 kg/m2.
Outcome assessment
The primary outcome of interest was all-cause
mortality. We also examined mortality from
CVD, diabetes, cancer, and respiratory diseases.
Survival status and mortality information through
to December 31, 2006, was confirmed by reviewing
death certificate files [underlying cause of death
documented by the International Classification of
Diseases, Ninth Revision (ICD-9), Department of
Health, Taiwan) using the unique national identi-
fication numbers of subjects. Death was considered
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to be caused by CVD if the primary cause of
death was CVD (ICD-9 codes: 390–398, 400–
404, 410–414, 420–429, 430–438, and 440–458).
Death from coronary heart disease was defined as
ICD-9 codes 410–414; death from cerebrovascu-
lar disease was defined as ICD-9 codes 430–438;
death from cancer was defined as ICD-9 codes
140–239; death from diabetes was defined as
ICD-9 code 250; and death from bronchial or lung
diseases was defined as ICD-9 codes 460–494,
496, and 510–519. The primary cause of death
was considered in this analysis.
Statistical analysis
SAS software (SAS Institute, Cary, NC, USA) was
used for all statistical analyses. Cox proportional
hazards regression model was used to investigate
the association of BMI categories with all-cause
mortality. Multivariable models were adjusted for
age, exercise habits, education level, alcohol con-
sumption and smoking status. Study subjects with
normal BMI (18.5–22.9 kg/m2) served as con-
trols. Mortality rates were calculated by dividing
the total number of deaths by the total number
of person–years follow-up. We calculated hazard
ratios (HRs) using the Cox proportional hazard
models with age as the time scale, as previously
described.16 The criteria for statistical significance
were p < 0.05 and a 95% confidence interval (CI)
of HR that excluded 1. The stratified partial pop-
ulation attributable risk (PAR) was calculated
using multivariate adjusted relative risk estimate
and macrosimulation as suggested by Spiegelman
et al.17
Results
Sample characteristics
The number of subjects with adequate data for
inclusion in this statistical analysis was 6603 (men/
women: 3316/3287). At initial examination in
1982, the subjects’ age ranged between 20 and
65 years. Their average age at the start of the study
was 47.8 ± 10.9 years, and their average BMI was
22.7 ± 3.3 kg/m2 (men, 22.5 ± 3.0 kg/m2; women,
22.9 ± 3.5 kg/m2). According to the World Health
Organization Asia–Pacific Guidelines 2000, the
prevalence of obesity (BMI: ≥ 25 kg/m2) was
17.86% in men and 21.51% in women. However,
according to the Department of Health, Taiwan,
the prevalence of obesity (BMI ≥ 27 kg/m2) was
6.88% in men and 11.6% in women. In our study,
61.1% of men and 2.8% of women were smokers.
The characteristics of the study sample are sum-
marized in Table 1.
Compared with the subjects with a normal
BMI, overweight and obese subjects showed greater
hypertension or diabetes prevalence; lower edu-
cation level; and greater age, serum total choles-
terol, serum triglyceride, fasting blood glucose,
and blood pressure levels.
BMI and mortality rates
At 24 years of follow-up that included nearly
140,263.3 person–years of observation, 1896 all-
cause deaths were identified (men: 1119; women:
777): 474 (25.0%) from CVD, 531 (28.0%) from
cancer, 188 (9.9%) from diabetes, 167 (8.8%)
from respiratory diseases, and 536 (28.3%) from
other causes (Table 2).
Mortality rates were greater in men than in
women. All-cause mortality rates increased mo-
notonically, with higher BMI values between
both the sexes (p for trend, < 0.001). There was a
J-shaped relationship between BMI and overall
mortality, as shown in Figure 1. Mortality rates
from any cause, CVD, diabetes, and cancer in-
creased with BMI. Similar J-shaped patterns were
observed for smokers and non-smokers (Table 1).
Mortality rates from respiratory diseases decreased
as BMI increased.
BMI and mortality risk
As shown in Figure 2, overweight (BMI: 23–
24.9 kg/m2) was significantly related to an in-
creased risk of death from diabetes or CVD. The
risk of death from diabetes and CVD was 93%
(HR: 1.93; 95% CI: 1.33–2.81) and 30% (HR: 1.30;
95% CI: 1.03–1.64) higher, respectively, in over-
weight subjects (BMI: 23–24.9 kg/m2) than in sub-
jects with normal BMI (BMI: 18.5–22.9 kg/m2).
Increased risk of mortality in overweight adults
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Compared to the subjects with normal BMI,
those with a BMI of 25–26.9 kg/m2 and ≥ 27 kg/
m2 were associated with a risk for all-cause mor-
tality of 1.28 (95% CI: 1.12–1.47) and 1.46
(95% CI; 1.27–1.68), respectively. All-cause mor-
tality was 46% higher in subjects with a BMI of
≥ 27 kg/m2 than in subjects with normal BMI. 
In subjects with a BMI of 25–26.9 kg/m2, the risk
of death from CVD was 1.43 (95% CI: 1.09–
1.89) and that from diabetes was 2.59 (95% CI:
1.71–3.90).
In Table 3, the stratified partial PAR of BMI 
of ≥ 27 kg/m2 for all-cause death was 4.6% (95%
CI: 2.8–6.4) when the normal BMI category was
Table 1. Differences in characteristics, blood pressure and clinical chemical analysis of the study population
according to body mass index categories
BMI categories (kg/m2)
< 18.5 18.5–22.9 23–24.9 25–26.9 ≥ 27
p
No. of subjects 461 3551 1259 722 610
Age at enrollment (yr) 46.1 ± 14.5 47.2 ± 11.6 48.9 ± 9.2 49.7 ± 8.6 49.5 ± 8.2 < 0.0001
Educational level (%)
None 28.2 29 29.9 25.5 33.4 < 0.0001
1–6 yr 39.9 47.3 46.5 52.6 52.8
> 6 yr 31.9 23.8 23.5 21.7 13.7
Smoking status (%) 29.9 35 28.7 31.2 25.1 < 0.0001
Alcohol consumption (%) 13.5 20 19.9 18.3 15.9 0.0026
Exercise habit (%) 73.7 79.7 80.3 78.5 74.8 0.0045
Hypertension (%) 7.4 15.8 25.8 31.1 45.8 < 0.0001
Diabetes (%) 8.3 9.5 10.7 14.3 15.9 0.0008
BMI (kg/m2) 17.5 ± 0.9 21.1 ± 1.2 23.9 ± 0.6 25.9 ± 0.6 29.5 ± 2.8 < 0.0001
Systolic blood pressure 112.8 ± 16.9 118.6 ± 17.5 124.8 ± 19.5 126.3 ± 18.9 132.7 ± 20.8 < 0.0001
(mmHg)
Diastolic blood pressure 70.9 ± 11.1 75.9 ± 11.4 80.2 ± 12.0 81.9 ± 11.6 85.6 ± 13.1 < 0.0001
(mmHg)
Fasting plasma glucose 95.7 ± 40.0 96.1 ± 42.9 98.3 ± 44.1 104.6 ± 50.6 108.0 ± 49.6 < 0.0001
(mg/dL)a
Total cholesterol (mg/dL)a 227.9 ± 62.4 236.4 ± 60.6 237.4 ± 61.7 244.9 ± 61.8 244.1 ± 61.8 0.0002
Triglyceride (mg/dL)a 155.1 ± 61.5 167.9 ± 68.4 178.3 ± 81.6 192.4 ± 90.9 193.9 ± 80.7 < 0.0001
No. of deaths 137 952 355 236 216
Follow-up time 9769.35 75,912.72 26,919.46 15,002.75 12,659.03
(person–years)
Cumulative mortality rate
(per 1000 person–years)
Total subjects 14.02 12.54 13.19 15.73 17.06 < 0.0001
Non-smokers 11.44 9.73 11.06 13.82 14.66 < 0.0001
Smokers 20.52 18.24 18.90 20.08 24.90 < 0.0001
Men 18.11 15.64 15.28 17.64 21.23 < 0.0001
Women 10.57 9.43 11.13 13.83 14.71 < 0.0001
Basic data are from the Six-Community Hypertension Intervention Project (SCHIP), 1982–1983. Values are indicated as means ±
standard deviation. Percentages might not total 100 because of rounding. aHalf of the participants were randomly sampled for blood
biochemical analysis in the following year. BMI = body mass index.
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Table 2. Major causes of death during follow-up in men and womena
Non-smokers Smokers
Both sexes Men Women Both sexes Men Women
All-cause mortality 1075 (100) 341 (100) 734 (100) 821 (100) 778 (100) 43 (100)
CVD mortality (ICD, 390–459)b 260 (24.2) 74 (21.7) 186 (25.3) 214 (26.1) 201 (25.8) 13 (30.2)
Coronary heart disease mortality 44 (4.1) 18 (5.3) 26 (3.5) 41 (5.0) 38 (4.9) 3 (7.0)
(ICD, 410–414)
Stroke mortality (ICD, 430–438) 137 (12.7) 33 (9.7) 104 (14.2) 115 (14.0) 111 (14.3) 4 (9.3)
Heart diseases (ICD, 401–429) 116 (10.8) 41 (12.0) 75 (10.2) 92 (11.2) 83 (10.7) 9 (20.9)
Diabetes mortality (ICD, 250) 127 (11.8) 27 (7.9) 100 (13.6) 61 (7.4) 57 (7.3) 4 (9.3)
Cancer mortality (ICD, 140–208) 292 (27.2) 89 (26.1) 203 (27.7) 239 (29.1) 224 (28.8) 15 (34.9)
Respiratory mortality 76 (7.1) 35 (10.3) 41 (5.6) 91 (11.1) 88 (11.3) 3 (7.0)
(ICD, 460–519)
Other causes 320 (29.8) 116 (34.0) 204 (27.8) 216 (26.3) 208 (26.8) 8 (18.6)
aData are presented as n (%); bdeath certificates obtained from the National Death Files. (ICD = International Classification of Diseases,
Ninth Revision); CVD = cardiovascular disease.
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Figure 1. Relationship of categories of the body mass index to cumulative all-cause mortality and specific cause mortality
in men and women.
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used as a reference level, and for diabetes, mor-
tality was 11.9% (95% CI: 8.1–15.7). The PAR for
CVD mortality and cancer mortality was 6.9%
and 3.9%, respectively.
Discussion
In this prospective study of an Asian population
with an obesity prevalence lower than that of
western populations, BMI appeared to be an in-
dependent predictor of all-cause, diabetes, cancer,
or CVD mortality. We confirmed that all-cause
mortality was consistently higher in subjects with
a BMI of ≥ 25 kg/m2 than in subjects with normal
BMI. The risk of CVD or diabetes mortality was
2–3-fold higher in subjects with a BMI of ≥ 27 kg/
m2 than in subjects with normal BMI. Overweight
(BMI: 23–24.9 kg/m2) was also associated with a
higher risk of diabetes or stroke mortality.
Our study shows that there is a J-shaped rela-
tionship between all-cause mortality and BMI. A
J-shaped association between BMI categories and
mortality rate has been observed in a few prospec-
tive studies.8–12,18,19 In our study, deaths from any
cause were lowest among subjects with a BMI of
Total subjects
All-cause mortality 23–24.9
25–26.9All-cause mortality
All-cause mortality
Diabetes mortality (250)
Diabetes mortality (250)
Diabetes mortality (250)
Cancer mortality (140–208)
Cancer mortality (140–208)
Cancer mortality (140–208)
CVD mortality (390–459)
CVD mortality (390–459)
CVD mortality (390–459)
BMI
categories
BMI
categories
BMI
categories
27–
23–24.9
25–26.9
27–
23–24.9
25–26.9
27–
23–24.9
25–26.9
27–
1.06
1.28
Hazard
ratio
1.46
1.93
2.59
3.03
1.03
1.27
1.54
1.30
1.43
1.95
0.94
1.12
1.27
1.33
1.71
2.01
0.81
0.99
1.17
1.03
1.09
1.49
Lower
limit
1.19
1.47
Upper
limit
1.68
2.81
3.90
4.58
1.30
1.64
2.02
1.64
1.89
2.57
Hazard ratio and 95% CI
0.1 0.2 0.5 1 2 5 10
Men
All-cause mortality 23–24.9
25–26.9All-cause mortality
All-cause mortality
Diabetes mortality (250)
Diabetes mortality (250)
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CVD mortality (390–459)
CVD mortality (390–459)
CVD mortality (390–459)
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23–24.9
25–26.9
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23–24.9
25–26.9
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23–24.9
25–26.9
27–
1.05
1.20
Hazard
ratio
1.49
2.39
2.32
5.10
1.04
1.36
1.51
1.34
1.15
1.97
0.90
1.09
1.20
1.38
1.24
2.78
0.78
0.98
1.02
1.00
0.78
1.33
Lower
limit
1.23
1.32
Upper
limit
1.85
4.13
4.34
9.37
1.40
1.90
2.23
1.79
1.70
2.92
Hazard ratio and 95% CI
0.1 0.2 0.5 1 2 5 10
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All-cause mortality 23–24.9
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Hazard ratio and 95% CI
Figure 2. Multivariate hazard ratios* for death from any cause and from specific causes according to body mass index
categories during 24-year follow-up period. *Cox regression model: adjusted for age, sex, alcohol consumption, smoking
status, education level, and exercise. Death certificates obtained from the National Death Files (International Classification
of Diseases, Ninth Revision). BMI = body mass index; CI = confidence interval; CVD = cardiovascular disease.
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18.5–22.9 kg/m2, which were slightly lower than
those reported in other studies on Asian and
western populations. Deaths from any cause were
the lowest among men and women with a BMI of
23.5–24.9 kg/m2 and 22.0–23.4 kg/m2, respec-
tively, in the CPS II,12 and among men and women
with a BMI of 24.0–24.9 kg/m2 and 25.0–26.9 kg/
m2, respectively, in Chinese subjects.11,20 The risk
of death from any cause was the lowest among
patients with a BMI of 23.0–24.9 kg/m2 in South
Korean subjects.10 Flegal et al8 have found that the
relative risk of all-cause mortality is low in subjects
with a BMI of 25–30kg/m2, often below 1, and that
this level of BMI could have protective effects.
The left side of the J-shaped association was
hypothesized to be a result of smoking-induced
respiratory diseases that lead to a decrease in body
weight, and thus increase mortality rate. In the U.S.
NIH-AARP Diet and Health Study, the J-shape as-
sociation disappeared and a linear association with
a positive slope was observed in subjects who
did not smoke.9 In the Nurses’ Health Study,
Hu et al have suggested that an increased risk of
death in the leanest group was primarily attrib-
uted to an increase in chronic lung diseases.21
Similar relationships between underweight sub-
jects and mortality have been shown in two Asian
cohorts.10,20 In this SCHIP cohort, a J-shaped 
association was observed even in non-smokers,
and there was a significant increase in mortality
from respiratory causes with decreasing BMI. To
reduce the potential for attributing an excess risk
of being underweight to mortality associated with
a wasting illness, we excluded all the subjects who
died during the first 3 years of follow-up. How-
ever, we observed an increased risk of death among
subjects who had a low BMI at enrollment, and
the increased risk of death was mainly from res-
piratory causes. With a BMI of < 18.5 kg/m2, the
HRs for death from respiratory causes were sig-
nificantly higher after adjusting for the confound-
ing factors of smoking.
The right side of the J-shaped curve for sub-
jects with a high BMI was associated with diabetes,
CVD, and cancer. Obesity and overweight together
are the second leading causes of preventable
death.22 Previous studies have found a strong as-
sociation between obesity and all-cause mortality
in the general population; primarily because of the
increased risk of CVD.23,24 BMI of > 30 kg/m2 has
been shown to be associated with an increased risk
of all-cause mortality in a cohort study of 7735
middle-aged men,23 and with a significantly in-
creased risk of death from CVD in the Nurses’
Health Study.24 In a cohort study of South Koreans,
a marked association between BMI and risk of
death from atherosclerotic cardiovascular causes
was found.25 However, the association between
BMI and the risk of cardiovascular death was not
significant in some studies, including a Chinese
cohort,11 CPS II,12 a United Kingdom cohort,26
and the Physicians’ Health Study.27
Table 3. Stratified partial population attributable risk of all-cause and specific diseases mortality associated
with body mass index ≥ 27 kg/m2
PARa and 95% CIb (%)
Total subjects Men Women
All-cause mortality 4.6 (2.8–6.4) 3.6 (1.0–6.1) 6.6 (3.2–9.9)
Coronary heart disease mortality (410–414)c 0.5 (−6.5–7.4) – 3.4 (−9.8–16.5)
Stroke mortality (430–438) 10.1 (6.3–13.8) 7.0 (1.8–12.2) 14.2 (5.8–22.3)
Diabetes mortality (250) 11.9 (8.1–15.7) 15.5 (8.8–22.0) 8.6 (1.6–15.5)
Cancer mortality (140–208) 3.9 (1.1–6.8) 2.1 (−1.4–5.6) 6.6 (0.9–12.3)
Heart diseases (401–429) 4.6 (2.8–6.4) 3.6 (1.0–6.1) 6.6 (3.2–9.9)
CVD mortality (390–459) 6.9 (4.0–9.7) 4.7 (0.7–8.6) 10.2 (4.5–15.9)
aStratified partial population attributable risk was estimated using multivariate adjusted relative risk estimate and macrosimulation
program that suggested by Spiegelman et al17; breference group was normal body mass index of 18.5–22.9 kg/m2; cnumbers in paren-
theses are codes from the International Classification of Diseases, Ninth Revision. PAR = population attributable risk; CI = confidence
interval; CVD = cardiovascular disease.
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Unlike the role of BMI as a risk factor of all-
cause mortality, that for cancer death remains
controversial. We observed that the risk of death
from cancer increased significantly among sub-
jects with a BMI of ≥ 27.0 kg/m2 at enrollment.
The risk of death from cancer increased markedly
among subjects with a BMI of > 30.0 kg/m2 in the
Korean Cancer Prevention Study,10 in the Nurses’
Health Study,21 and in CPS I and II.3,12 However,
in a meta-analysis, McGee has found that obesity
was not associated with excess mortality from
cancer.28 In the meta-analysis, pooled estimates
of the risk of death from cancer were obtained by
comparing the risks in obese subjects with those
in normal-weight subjects; BMI was not found to
be an independent risk factor for death from can-
cer (HR: 1.06 for men and 1.10 for women).
Nonetheless, our findings indicated that the long-
term risk of death from cancer increased clearly
among subjects with a BMI ≥27.0 kg/m2 (HR: 1.51
for men and 1.55 for women).
Current World Health Organization (WHO)
guidelines for western populations suggest that
overweight should be defined as a BMI 25–
29.9 kg/m2 and obesity as a BMI ≥ 30 kg/m2. More
specifically, there is a greater mortality risk at lower
BMI in Asian populations.15,29 Previous studies
have shown that the health risks associated with
BMI become apparent around a BMI of 23 kg/
m2 for Taiwanese populations and not around
25 kg/m2, as is observed in western popula-
tions.30 Cutoff values for defining overweight and
obesity in Asian populations should be lower
than those in Western populations. Our findings
could prove to be useful in the evaluation of this
recommendation.
The following are the strengths of the study:
large number of participants, prospective design,
community-based study, and long follow-up 
period. We excluded early deaths to mitigate the
influence of existing disease and to minimize
potential bias. Actual measurements of height
and weight rather than relying on self-reported
data are an additional strength of this study. The
limitations of this study include a baseline mea-
surement of BMI to predict mortality several
years in the future. When interpreting our results
with regard to baseline BMI, it is important to note
that we were unable to evaluate weight change
(body fat or fat distribution) during the follow-
up period. We did not measure waist circumfer-
ence during the baseline survey. Flegal et al31 have
found that estimates for all-cause and obesity-
related mortality showed no statistically signifi-
cant or systematic differences between BMI and
waist circumference. The association of death and
large waist circumference in Asian populations
needs to be analyzed further. Additionally, we
could not obtain accurate information on the oc-
currence of diseases and history of treatment
during the follow-up period. Another limitation
of our study is that, in Taiwan, data concerning
the cause of death are not completely reliable, al-
though we did obtain the information on deaths
from death certificates issued by the Department
of Health, and they seemed to be accurate.
Ascertainment of bias in outcome assessment can
be restricted if the main outcome is solid or ob-
jective (e.g. death). We considered that estimation
of death from all causes or cancer was accurate.
We included deaths from cardiac and cerebrovas-
cular diseases into a single group as CVD deaths
for the analyses, to prevent diagnostic problems.
In the Cox model of diabetes mortality, those who
died from diabetes were considered non-censors,
and survivors or those who died from diseases
other than diabetes were considered censors.
Hence, our relative risks of obesity for diabetes
morality might have been underestimated. These
positive association results might have been more
significant if we could have precisely ascertained
diabetes mortality.
In conclusion, we determined the association
of BMI in the overweight and obese range with
an increased risk of all-cause death and death
from diabetes, atherosclerotic cardiovascular dis-
eases, and cancer. BMI categories of ≥ 23 kg/m2,
≥ 25 kg/m2, and ≥ 27 kg/m2 were found to be pos-
itively associated with mortality from diabetes
and CVD, all causes, and cancer, respectively.
There was a J-shaped relationship between BMI
and all-cause mortality in Taiwanese adults.
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